MedPath

Haloperidol Lactate

Haloperidol Injection, USP (For Immediate Release) Rx only

Approved
Approval ID

65df5d2d-79aa-41d4-866a-566e520320f7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 7, 2023

Manufacturers
FDA

Henry Schein, Inc.

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Haloperidol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9871
Application NumberANDA078347
Product Classification
M
Marketing Category
C73584
G
Generic Name
Haloperidol
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateJanuary 11, 2022
FDA Product Classification

INGREDIENTS (5)

HALOPERIDOL LACTATEActive
Quantity: 5 mg in 1 mL
Code: 6387S86PK3
Classification: ACTIM
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol Lactate - FDA Drug Approval Details